Back
ESC Professional Premium Access

Incidence and factors associated with de novo atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis

Session: Amyloidosis and aortic stenosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor C. Fumagalli (Florence, IT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Carlo Fumagalli

Careggi University Hospital (AOUC), Florence (Italy)
0 follower

6 more presentations in this session

Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a single center experience

Speaker: Doctor L. Scudeler (Turin, IT)

Access
Abstract
Slides
Like
Thumbnail

NNC6019-0001, a humanized monoclonal antibody, in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): rationale and study design of a phase 2, randomized, placebo-controlled trial

Speaker: Professor M. Fontana (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Change in echocardiography in patients with transthyretin amyloid cardiomyopathy with tafamidis treatment.

Speaker: Doctor M. Morioka (Kumamoto, JP)

Access
Abstract
Slides
Like
Thumbnail

Valve disease in cardiac amyloidosis: an echocardiographic score

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Global longitudinal strain and quantitative sensory testing in pre-symptomatic patients with mutation for transthyretin amyloidosis

Speaker: Associate Professor M. Losi (Napoly, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Amyloidosis and aortic stenosis

Speakers: Doctor C. Fumagalli, Doctor L. Scudeler, Professor M. Fontana, Doctor M. Morioka, Doctor A. Aimo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources